Why Pediatrix Medical Group Inc’s (MD) Stock Is Up 8.09%

By Tudor Pop
September 26, 2024
Featured Tickers:
MD

Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Pediatrix Medical Group Inc before investing.

In this article, we go over a few key elements for understanding Pediatrix Medical Group Inc’s stock price such as:

  • Pediatrix Medical Group Inc’s current stock price and volume
  • Why Pediatrix Medical Group Inc’s stock price changed recently
  • Upgrades and downgrades for MD from analysts
  • MD’s stock price momentum as measured by its relative strength

About Pediatrix Medical Group Inc (MD)

Before we jump into Pediatrix Medical Group Inc’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Company’s affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.

Want to learn more about Pediatrix Medical Group Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Pediatrix Medical Group Inc.

Learn More About A+ Investor

Pediatrix Medical Group Inc’s Stock Price as of Market Close

As of September 26, 2024, 4:00 PM, CST, Pediatrix Medical Group Inc’s stock price was $11.36.

Pediatrix Medical Group Inc is up 8.09% from its previous closing price of $10.51.

During the last market session, Pediatrix Medical Group Inc’s stock traded between $10.40 and $10.78. Currently, there are 83.33 million shares of Pediatrix Medical Group Inc stock available for purchase.

Unfortunately, Pediatrix Medical Group Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Pediatrix Medical Group Inc Stock Price History

Pediatrix Medical Group Inc’s (MD) price is currently up 4.6% so far this month.

During the month of September, Pediatrix Medical Group Inc’s stock price has reached a high of $11.77 and a low of $10.06.

Over the last year, Pediatrix Medical Group Inc has hit prices as high as $13.01 and as low as $6.62. Year to date, Pediatrix Medical Group Inc’s stock is down 23.55%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Pediatrix Medical Group Inc Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of September 25, 2024, there were 2 analysts who downgraded Pediatrix Medical Group Inc’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Pediatrix Medical Group Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Pediatrix Medical Group Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Pediatrix Medical Group Inc’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Pediatrix Medical Group Inc (MD) by visiting AAII Stock Evaluator.

Relative Price Strength of Pediatrix Medical Group Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of September 25, 2024, Pediatrix Medical Group Inc has a weighted four-quarter relative price strength of 2.68%, which translates to a Momentum Score of 71 and is considered to be Strong.

Want to learn more about how Pediatrix Medical Group Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Pediatrix Medical Group Inc Stock Price: Bottom Line

As of September 26, 2024, Pediatrix Medical Group Inc’s stock price is $11.36, which is up 8.09% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Pediatrix Medical Group Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.

Learn More About A+ Investor

Find New Stock Opportunities With Included With AAII Platinum
High Relative Dividend
Yield Screen:
8.7% Compared to S&P 500
at only 6.9%

Since Inception. Data as of 12/31/2024.




Try AAII Platinum and get full access to
769.3% Stock Superstars Portfolio Total Return Since Inception
Compare to:
710.3% iShare DOW Jones
U.S. Index ETF (IYY)

SSR Group 3 O'Shaughnessy portfolio has a 411.2% gain since inception performance compared to IYY at only 119.1%% Performance as of 11/29/24.

Get your free copy of our special report analyzing the tech stocks most likely to outperform the market.

Download the FREE Report Here:

BECOME A MEMBER FOR ONLY $2

Get access to powerful investment discovery tools and a wealth of investment education to help you achieve your financial goals.